Matrix Metalloproteinase-1 and -9 Promoter Polymorphisms and Endometrial Carcinoma Risk in a Japanese Population

Journal of the Society for Gynecologic Investigation

Volumn 13, Issue 7, 2006, Pages 523-529

  Sugimoto, Makoto ^a   Yoshida, Shigeki ^a   Kennedy, Stephen ^b   Deguchi, Masashi ^a   Ohara, Noriyuki ^a   Maruo, Takeshi ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

endometrial carcinoma; gene polymorphism; MMP 1; MMP 9; restriction fragment length polymorphism

Indexed keywords

GELATINASE B; INTERSTITIAL COLLAGENASE;

ADULT; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; DNA POLYMORPHISM; ENDOMETRIUM CARCINOMA; ENZYME POLYMORPHISM; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC VARIABILITY; HISTOLOGY; HUMAN; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; POPULATION GENETICS; PRIORITY JOURNAL; PROMOTER REGION; RESTRICTION FRAGMENT; SINGLE NUCLEOTIDE POLYMORPHISM;

ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; ENDOMETRIAL NEOPLASMS; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; MATRIX METALLOPROTEINASE 1; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PROMOTER REGIONS (GENETICS); PROMOTER REGIONS, GENETIC;

EID: 33749529723     PISSN: 10715576     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsgi.2006.07.001     Document Type: Article

References (40)

1. Niwa Y., Hirose K., Matsuo K., et al. Association of p73 G4C14-to-A4T14 polymorphism at exon 2 and p53 Arg72Pro polymorphism with the risk of endometrial cancer in Japanese subjects. Cancer Lett 219 (2004) 183-190
2. Emons G., Fleckenstein G., Hinney B., Huschmand A., and Heyl W. Hormonal interactions in endometrial cancer. Endocr Relat Cancer 7 (2000) 227-242
3. Gu Z.D., Chen K.N., Li M., Gu J., and Li J.Y. Clinical significance of matrix metalloproteinase-9 expression in esophageal squamous cell carcinoma. World J Gastroenterol 11 (2005) 871-874
4. Constance E., Brinckerhoff, Joni L., and Ulrike B. Interstitial collagenases as markers of tumor progression. Clin Cancer Res 6 (2000) 4823-4830
5. Xiaoping M., Chunyuan Y., Wen T., Ping X., Gang L., Wenfu L., and Dongxin L. A functional polymorphism in the matrix metalloproteinase-2 gene promoter (-1306 C/T) is associated with risk of development but not metastasis of gastric cardia adenocarcinoma. Cancer Res 63 (2003) 3987-3990
6. Sofia J., Carl W., Dirk H., Andreas M., Andreas H., and Per E. Allele-specific regulation of matrix metalloproteinase-7 promoter activity is associated with coronary artery luminal dimensions among hypercholesterolemic patients. Arterioscler Thromb Vasc Biol 21 (2001) 1834-1839
7. Kanamori Y., Matsushima M., Minaguchi T., et al. Correlation between expression of the matrix metalloproteinase-1 gene in ovarian cancers and an insertion/deletion polymorphism in its promoter region. Cancer Res 59 (1999) 4225-4227
8. Walter W., Dorothy R., Joni L., et al. Loss of heterozygosity on chromosome 11q22-23 in melanoma is associated with retention of the insertion polymorphism in the matrix metalloproteinase-1 promoter. Am J Pathol 158 (2001) 691-697
9. Kroeger P.E., Sarge K.D., and Morimoto R.I. Mouse heat shock transcription factors 1 and 2 prefer a trimeric binding site but interact differently with the HSP70 heat shock element. Mol Cell Biol 13 (1993) 3370-3383
10. Tornvall P., Bavenholm P., Landou C., de Faire U., and Hamsten A. Relation of plasma levels and composition of apolipoprotein B-containing lipoproteins to angiographically defined coronary artery disease in young patients with myocardial infarction. Circulation 88 (1993) 2180-2189
11. Walter D.H., Schachinger V., Elsner M., Dimmeler S., and Zeiher A.M. Platelet glycoprotein IIIa polymorphisms and risk of coronary stent thrombosis. Lancet 350 (1997) 1217-1219
12. Colby A., Charles I., Jennifer J., and Constance E. Potential for the 2G single nucleotide polymorphisms in the promoter of matrix metalloproteinase to enhance gene expression in normal stromal cells. Cancer Res 62 (2002) 7200-7202
13. Miyata Y., Koga S., Kanda S., Nishikido M., Hayashi T., and Kanetake H. Expression of cyclooxygenase-2 in renal cell carcinoma: Correlation with tumor cell proliferation, apoptosis, angiogenesis, expression of matrix metalloproteinase-2, and survival. Clin Cancer Res 9 (2003) 1741-1749
14. Shu Y., Sahar D., Steven J., et al. Invasiveness of cutaneous malignant melanoma is influenced by matrix metalloproteinase 1 gene polymorphism. Cancer Res 61 (2001) 1296-1298
15. Giorgio G., Maria L., Jacopo M., et al. Matrix metalloproteinase 1 promoter polymorphism 1G/2G is correlated with colorectal cancer invasiveness. Clin Cancer Res 7 (2001) 2344-2346
16. Yong Z., Margaret R., Lei L., Gordon B., and Xifeng W. A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter enhances lung cancer susceptibility. Cancer Res 61 (2001) 7825-7829
17. Stefan B., Hans J., Odette P., et al. Plasma concentrations and genetic variation of matrix metalloproteinase 9 and prognosis of patients with cardiovascular disease. Circulation 107 (2003) 1579-1585
18. David G., Amin K., Pamela L., Howard Y., and Robert E. Functional polymorphism in the matrix metalloproteinase 9 promoter as a potential risk factor for intracranial aneurysm. Stroke 30 (1999) 2612-2616
19. Pedro E., Samuel P., Mary S., et al. A polymorphism in the matrix metalloproteinase-9 promoter is associated with increased risk of preterm premature rupture of membranes in African Americans. Mol Hum Reprod 8 (2002) 494-501
20. Itoh T., Tanioka M., Yoshida H., Nishimoto H., and Itohara S. Reduced angiogenesis and tumor progression in gelatinase A-deficient mice. Cancer Res 58 (1998) 1048-1051
21. Brooks P.C., Silletti S., von Schalscha T.L., Friedlander M., and Cheresh D.A. Disruption of angiogenesis by PEX, a noncatalytic metalloproteinase fragment with integrin binding activity. Cell 92 (1998) 391-400
22. Turpeenniemi-Hujanen T. Gelatinases and their natural inhibitors as prognostic indicators in solid cancers. Biochimie 87 (2005) 287-297
23. Yimin W., Shumei F., Lizhen W., et al. No association between the C-1562T polymorphism in the matrix metalloproteinase-9 gene and non-small cell lung carcinoma. Lung Cancer 49 (2005) 155-161
24. Morgia G., Falsaperla M., Malaponte G., et al. Matrix metalloproteinase as diagnostic (MMP-13) and prognostic (MMP-2, MMP-9) markers of prostate cancer. Urol Res 33 (2004) 44-50
25. Ouyang Y.W., Peng Z.L., Yao X.Y., Liu S.L., and He Y.D. The expression of matrix metalloproteinase-2 and -9 in cervical cancer and a study of their relation. Sichuan Da Xue Xue Bao Yi Xue Ban 35 (2004) 330-333
26. Aglund K., Rauvala M., Puistola U., et al. Gelatinases A and B (MMP-2 and MMP-9) in endometrial cancer-MMP-9 correlates to the grade and the stage. Gynecol Oncol 94 (2004) 699-704
27. Matsumura S., Oue S., Nakayama H., et al. A single nucleotide polymorphism in the MMP-9 promoter affects tumor progression and invasive phenotype of gastric cancer. J Cancer Res Clin Oncol 131 (2005) 19-25
28. Nishioka Y., Kobayashi K., Sagae S., et al. A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter in endometrial carcinomas. Jpn J Cancer Res 91 (2000) 612-615
29. Santos M.C., Campos M.I., Souza A.P., Trevilatto P.C., and Line S.R. Analysis of MMP-1 and MMP-9 promoter polymorphisms in early osseointegrated implant failure. Int J Oral Maxillofac Implants 19 (2004) 38-43
30. Matsumura S., Oue N., Kitadai Y., et al. A single nucleotide polymorphism in the MMP-1 promoter is correlated with histological differentiation of gastric cancer. J Cancer Res Clin Oncol 53 (2004) 259-265
31. Yamada Y., Ando F., Niino N., and Shimokata H. Association of a polymorphism of the matrix metalloproteinase-9 gene with bone mineral density in Japanese men. Metabolism 53 (2004) 135-137
32. Zhang X.M., Miao X.P., Xiong P., et al. Association of functional polymorphisms in matrix metalloproteinase-2 (MMP-2) and MMP-9 genes with risk of gastric cancer in a Chinese population. Ai Zheng 23 (2004) 1233-1237
33. Grieu F., Li W.Q., and Iacopetta B. Genetic polymorphisms in the MMP-2 and MMP-9 genes and breast cancer phenotype. Breast Cancer Res Treat 88 (2004) 197-204
34. Lai H.C., Chu C.M., Lin Y.W., Chang C.C., Nieh S., Yu M.H., and Chu T.Y. Matrix metalloproteinase-1 gene polymorphisms as a prognostic predictor of invasive cervical cancer. Gynecol Oncol 96 (2005) 314-319
35. Giorgio G., Maria L., Marco D., Olivia T., Emma G., and Roberto S. Matrix metalloproteinase-1 and matrix metalloproteinase-3 gene promoter polymorphism are associated with carotid artery stenosis. Stroke 33 (2002) 2408-2412
36. Ghilardi G., Biondi M.L., Caputo M., et al. A single nucleotide polymorphism in the matrix metalloproteinase-3 promoter enhances breast cancer susceptibility. Clin Cancer Res 2 (2002) 3820-3823
37. Hinoda Y., Okayama N., Takano N., Fujimura K., Suehiro Y., and Hamanaka Y. Association of functional polymorphisms of matrix metalloproteinase (MMP)-9 and MMP-3 genes with colorectal cancer. Int J Cancer 102 (2002) 526-529
38. Jin X., Kuang G., Wei L.Z., et al. No association of the matrix metalloproteinase 1 promoter polymorphism with susceptibility to esophageal squamous cell carcinoma and gastric cardiac adenocarcinoma in northern China. World J Gastroenterol 11 (2005) 2385-2389
39. Przybylowska K., Zielinska J., Zadrozny M., et al. An association between the matrix metalloproteinase 1 promoter gene polymorphism and lymph node metastasis in breast cancer. J Exp Clin Cancer Res 23 (2004) 121-125
40. Wenham R.M., Calingaert B., Ali S., et al. Matrix metalloproteinase-1 gene promoter polymorphism and risk of ovarian cancer. J Soc Gynecol Investig 10 (2003) 381-387